home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A Blueprint for Better Cholesterol-Lowering Drugs

 
  May, 10 2001 18:13
your information resource in human molecular genetics
 
     

A strategy for designing more effective
cholesterol-lowering drugs may come
from the first studies of the structural
mechanism by which the widely
prescribed statin drugs, such as Lipitor
and Zocor, lower cholesterol.
Although the statin drugs -- which are regarded
as blockbuster drugs for the
pharmaceutical industry -- are effective at
reducing cholesterol, the new
structural studies suggest there is room for
improvement.

Research published in the May 11, 2001,
issue of the journal Science.

For the full story go to
http://www.hhmi.org/news/deisenhofer.html


Message posted by: hhmi

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.